Generální ředitelství pro zdraví a bezpečnost potravin
European Rare Diseases Day 2015: the top facts on EU Action At the European Commission, we take an integrated approach to further improve the access and equity to prevention, diagnosis and treatment for patients suffering from a rare disease throughout the European Union.
SCENIHR final opinion on the safety of BPA in medical devices This opinion of the Scientific Committee on Emerging and newly identified risks assesses the safety of the use of bisphenol A in medical devices, provides limit values for BPA release from medical devices and identifies patient group, e.g. infants, pregnant and breastfeeding women who would be particularly at risk.
Antimicrobial Resistance to remain a priority in the EU beyond 2016 The Commission publishes a progress report on its five year Action Plan Against Antimicrobial Resistance (AMR). The Plan takes a holistic approach and sets out 12 concrete actions both in the human and the veterinary field.
Public consultation on the preliminary opinion ‘Competition among health care providers in the European Union – Investigating policy options’. Interested parties are invited to provide comments on this preliminary opinion of the Expert Panel on effective ways of investing in Health (EXPH). The consultation will run until 8 April 2015 via the EXPH website